397 related articles for article (PubMed ID: 34007019)
1. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.
Haghpanah A; Masjedi F; Salehipour M; Hosseinpour A; Roozbeh J; Dehghani A
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):27-38. PubMed ID: 34007019
[TBL] [Abstract][Full Text] [Related]
2. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
3. The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS).
Balacescu MS; Ene CV; Georgescu DE; Bulai CA; Militaru A; Ene CD; Vacaroiu IA; Georgescu DA; Geavlete BF; Geavlete P
Cureus; 2024 Apr; 16(4):e59148. PubMed ID: 38803716
[TBL] [Abstract][Full Text] [Related]
4. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration.
Liu AQ; Chiu PK; Yee SC; Ng CF; Teoh JY
J Intern Med; 2023 Dec; 294(6):775-783. PubMed ID: 37849423
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
[TBL] [Abstract][Full Text] [Related]
7. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
María Molero J; Miñana B; Palacios-Moreno JM; Téllez Martínez-Fornes M; Lorite Mingot D; Agra Rolán A; Carreño Á; Cuervo Pinto R
Int J Clin Pract; 2020 Nov; 74(11):e13602. PubMed ID: 32609933
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 pandemic on lower urinary tract symptoms in patients with benign prostatic hyperplasia and predictors of urine retention in such patients.
Nabeeh H; Ibrahim A; Taha DE; Talaat M; Abdelbaky TM
Low Urin Tract Symptoms; 2022 Jan; 14(1):41-46. PubMed ID: 34435456
[TBL] [Abstract][Full Text] [Related]
9. Is There a Link Between Non-Alcoholic Fatty Liver Disease and Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms: A Systematic Review and a Meta-Analysis.
Besiroglu H; Kadihasanoglu M
Metab Syndr Relat Disord; 2023 Sep; 21(7):370-377. PubMed ID: 37341680
[No Abstract] [Full Text] [Related]
10. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
11. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
[TBL] [Abstract][Full Text] [Related]
12. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
13. Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis.
Xin C; Fan H; Xie J; Hu J; Sun X; Liu Q
Front Endocrinol (Lausanne); 2021; 12():741748. PubMed ID: 35178024
[TBL] [Abstract][Full Text] [Related]
14. [Benign prostatic hyperplasia management during COVID-19 pandemia.].
Medina-Polo J; Téigell Tobar J; Romero-Otero J; Carballido-Rodríguez J; Domínguez-Esteban M; Martínez-Berganza ML; Miñana-López B; Unda Urzaiz JM; Rodríguez-Antolín A
Arch Esp Urol; 2020 Jun; 73(5):405-412. PubMed ID: 32538810
[TBL] [Abstract][Full Text] [Related]
15. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
Speakman M; Kirby R; Doyle S; Ioannou C
BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
[TBL] [Abstract][Full Text] [Related]
16. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
17. The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men.
Lu Y; Fan S; Song Y; Liu K; Zhou K; Kang J; Wang S; Yang Y; Liu X
World J Urol; 2021 Jul; 39(7):2645-2653. PubMed ID: 33141318
[TBL] [Abstract][Full Text] [Related]
18. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
De Nunzio C; Salonia A; Gacci M; Ficarra V
World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
[TBL] [Abstract][Full Text] [Related]
19. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
20. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
